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Abstract
Determining the body fluids where secreted proteins can be secreted into is important for protein function annotation and
disease biomarker discovery. In this study, we developed a network-based method to predict which kind of body fluids
human proteins can be secreted into. For a newly constructed benchmark dataset that consists of 529 human-secreted
proteins, the prediction accuracy for the most possible body fluid location predicted by our method via the jackknife test
was 79.02%, significantly higher than the success rate by a random guess (29.36%). The likelihood that the predicted body
fluids of the first four orders contain all the true body fluids where the proteins can be secreted into is 62.94%. Our method
was further demonstrated with two independent datasets: one contains 57 proteins that can be secreted into blood; while
the other contains 61 proteins that can be secreted into plasma/serum and were possible biomarkers associated with
various cancers. For the 57 proteins in first dataset, 55 were correctly predicted as blood-secrete proteins. For the 61
proteins in the second dataset, 58 were predicted to be most possible in plasma/serum. These encouraging results indicate
that the network-based prediction method is quite promising. It is anticipated that the method will benefit the relevant
areas for both basic research and drug development.
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Introduction
Protein secretion is a universal biological process occurring in all
organisms. Secreted proteins such as hormones, digestive enzymes,
neurotransmitters as well as antibodies, play vital regulatory roles
in various biological activities such as reproduction, digestion,
nerve conduction and immunization [1]. The studies on the
secreted proteins under different physiological and pathological
conditions in different growth and development stages can deepen
the understanding of many biological phenomena. Under the
condition of the disease, some secreted proteins showed abnormal
concentration level [2]. In recent years, several genes encoding
secreted proteins have been found to be consistently over-
expressed in various cancer specimens [3,4,5]. For example,
MIC1 gene has been observed to be over-expressed in breast,
colorectal and prostate cancer patients [5]. These proteins that
could be detected in blood, urine or other body fluids are more
suitable to serve as biomarkers for diagnosis [6]. This is because
the body fluid test (e.g. blood test or urine test) is less invasive,
cheaper, and easier to collect and process samples than tissue
biopsy test [7,8] since the latter requires surgery to get the disease
tissues. Besides, identification of body fluids where proteins can be
secreted into is very helpful for protein function annotation and
biomarker discovery.
However, how to realize the identification is still a big challenge
even having the advanced proteomics technologies because there
are a large amount of proteins with a variety of modifications in
body fluids [8]. To address this problem, let us resort to
computational approaches. In the past two decades, many studies
have focused on predicting the subcellular locations of proteins in
both prokaryotes and eukaryotes (see, e.g., [9,10,11,12,13,14,15,
16,17,18,19,20,21] as well as a long list of the relevant references
in a comprehensive review [22]). Unfortunately, none of the
aforementioned methods was aimed at identifying the final
locations where the extracellular proteins are secreted. The
present study was initiated in an attempt to address this problem,
with a focus on human secreted proteins and a novel approach via
protein-protein interaction (PPI) network.
According to a recent comprehensive review [23], to establish a
really useful statistical predictor for a protein system, we need to
consider the following procedures: (i) construct or select a valid
benchmark dataset to train and test the predictor; (ii) formulate the
protein samples with an effective mathematical expression that can
truly reflect their intrinsic correlation with the attribute to be
predicted; (iii) introduce or develop a powerful algorithm (or
engine) to operate the prediction; (iv) properly perform cross-
validation tests to objectively evaluate the anticipated accuracy of
the predictor. Below, let us describe how to deal with these steps.
Materials and Methods
Training dataset
The human secreted proteins were retrieved from UniProt [24].
The detailed procedures for collecting the human secreted protein
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uniprot.org/ (Release 2011_05). (2) Click the button ‘‘Fields’’,
followed by selecting ‘‘Subcellular location’’ for Advanced
Search, ‘‘Secreted’’ for Term, ‘‘Homo sapiens’’ for Organism,
and ‘‘Experimental’’ for Confidence. (3) Click Add & Search.
Thus we collected a total of 1,019 experiment-validated human
secreted proteins. Subsequently, these proteins were mapped to 11
different kinds of body fluids contained in the human body fluid
database ‘‘Sys-BodyFluid’’ [25] (http://lifecenter.sgst.cn/bodyfluid/),
where the body fluid proteome data was manually collected from 50
peer-review publications. Finally, a total of 682 human proteins
have been obtained that can be secreted into the aforementioned
body fluids.
The human protein-protein interaction (PPI) networks were
retrieved from STRING [26,27] (http://string.embl.de/), which is
a database dedicated to both physical and functional interactions.
Information derived from 3 kinds of sources (high-throughput
experiments, mining of databases and literature, and prediction
from genomic context analysis) was integrated into several PPI
networks. As done by previous investigators in using the intuitive
graphic representation to deal with complicated biological systems,
such as enzyme-catalyzed system [28,29,30], protein-folding
system [31], and drug metabolism system [32], here the PPI
network can also be intuitively expressed via a graph, in which
each of the proteins is represented by a node, and the interaction is
represented by the edge between two nodes. The edge is weighted
by the interaction confidence, i.e., the likelihood that the inter-
action exists between two nodes. The interaction confidence score
of two proteins is obtained as follows: first, the interactions from
each source were scored by benchmarking them against a com-
mon reference set; then these scores were combined in the naive
Bayesian fashion [26].
Of the 682 human secreted proteins, we have found that 153
proteins have no PPI information nor interact with any of the
other secreted proteins, while 529 proteins interact with at least
one of the other proteins in the human PPI network from
STRING. Thus, we obtained a working PPI network that consists
of 529 nodes (proteins) and 27,176 interaction units. Such 529
human secreted proteins in the newly constructed PPI network
were used as the training dataset for developing the current
network-based method.
The distribution of the 529 human secreted proteins classified
according to the 11 different types of body fluids is shown in
Table 1, from which we can see that the sum of numbers in
column 3 is 1708 that is much more than 529, the number of
secreted proteins. This is because many proteins can be secreted
into more than one body fluid [25], as illustrated in Figure 1.A s
we can see from the figure, of the 529 human secreted proteins,
179 can be secreted into one body fluid, and 350 proteins can be
secreted into two or more different types of body fluids. Therefore,
we are to deal with a multi-label classification problem.
Testing datasets
Two testing datasets were used in this study. The first one
contains 57 blood-secreted proteins, which was obtained as
follows. First of all, 305 blood-secreted proteins were retrieved
from the positive dataset in [33], where the proteins met the
criteria that they were not only secreted but also serum/plasma
detected. Of the 305 proteins thus obtained, 172 were excluded
because they occurred the training dataset, and 76 proteins were
also excluded because they had no interaction with the proteins in
the training dataset and hence could not be processed by the
current method (see the Network-based Method section). The
remaining 57 blood-secreted proteins were used to test our method
(Table S1).
The second testing dataset contains 61 proteins as obtained as
follows. From [33], we first collected 122 abnormally expressed
proteins involved with various cancers as indicated by many
published proteomics studies. From these proteins, we obtained 77
plasma/serum secreted proteins. After removing those that had
been contained in the training dataset and those that had no
interaction with the proteins in the training dataset, we finally
obtained the remaining 61 possible marker proteins (Table S2)
for the second testing dataset.
Network-based method
Many interacting proteins must co-occur in the same location to
participate in the biological processes [34]. Accordingly, we can
presume that the interacting secreted proteins are likely to be
secreted into the same body fluids. In other words, the following
assumptions would be valid.
Given a query protein, the higher interaction confidence score
between it and its interacting counterpart, the more likely they are
to be secreted into the same body fluid. Also, the more its
interacting proteins in a certain body fluid, the more likely it is to
be secreted into such body fluid [35]. With these points in mind,
the body fluids that secreted proteins can be secreted into can be
predicted as follows.
First, let us denote the n proteins in the PPI network as
P1,P2,   ,Pn fg and the 11 body fluids as F~½F1,F2,:::,F11 ,
where F1 stands for the ‘‘Amniotic fluid’’, F2 the ‘‘Bronchoalveolar
lavage fluid’’, F3 the ‘‘Cerebrospinal fluid’’, and so forth (cf.
Table 1). Thus, the body fluids that the proteins in the PPI
network is secreted into can be described as
F~
f1,1 f1,2     f1,j     f1,11
f2,1 f2,2     f2,j     f2,11
. .
. . .
. . .
. . .
. . .
. . .
.
fi,1 fi,2     fi,j     fi,11
. .
. . .
. . .
. . .
. . .
. . .
.
fn,1 fn,2     fn,j     fn,11
2
6 6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 7 5
i~1,2,   ,n
j~1,2,   ,11
  
ð1Þ
Table 1. A breakdown of the 529 human secreted proteins in
the training dataset according to the 11 different types of
body fluids into which they can be secreted.
Type Body fluid Number of proteins in dataset
1 Amniotic fluid 192
2 Bronchoalveolar lavage fluid 65
3 Cerebrospinal fluid 204
4 Milk 71
5 Nipple aspiration fluid 37
6 Plasma/Serum 418
7 Saliva 175
8 Seminal fluid 155
9 Synovial fluid 63
10 Tear 84
11 Urine 244
Sum 1,708
doi:10.1371/journal.pone.0022989.t001
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fi,j~
1, if protein Pi can be secreted into the j-th
body fluid Fj
0, otherwise
8
> <
> :
ð2Þ
For several query proteins P1,P2,   ,Pm fg , their interactions with
the n proteins in the PPI network can be described as
W~
w1,1 w1,2     w1,i     w1,n
w2,1 w2,2     w2,i     w2,n
. .
. . .
. . .
. . .
. . .
. . .
.
wk,1 wk,2     wk,i     wk,n
. .
. . .
. . .
. . .
. . .
. . .
.
wm,1 wm,2     wm,i     wm,n
2
6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 5
i~1,2,   ,n
k~1,2,   ,m
  
ð3Þ
where wk,i denotes the interaction confidence score [27] between
Pk and Pi. If there is no interaction between Pk and Pi, we have
wk,i~0. Since no self-interaction exists in the PPI network, wk,i~0
if k~i. Now, let us use S(Pk[j)to denote the likelihood that the
query protein Pk is secreted into the j-th body fluid Fj. Thus, the
likelihood that the m query proteins are secreted into the 11 body
fluids can be formulated as
M~W:F
~
w1,1 w1,2     w1,i     w1,n
w2,1 w2,2     w2,i     w2,n
. .
. . .
. . .
. . .
. . .
. . .
.
wk,1 wk,2     wk,i     wk,n
. .
. . .
. . .
. . .
. . .
. . .
.
wm,1 wm,2     wm,i     wm,n
2
6 6 6 6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 7 7 7 5
f1,1 f1,2     f1,j     f1,11
f2,1 f2,2     f2,j     f2,11
. .
. . .
. . .
. . .
. . .
. . .
.
fi,1 fi,2     fi,j     fi,11
. .
. . .
. . .
. . .
. . .
. . .
.
fn,1 fn,2     fn,j     fn,11
2
6 6 6 6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 7 7 7 5
~
S P1[1 ðÞ S P1[2 ðÞ       S P1[j ðÞ       S P1[11 ðÞ
S P2[1 ðÞ S P2[2 ðÞ       S P2[j ðÞ       S P2[11 ðÞ
. .
. . .
. . .
. . .
. . .
. . .
.
S Pk[1 ðÞ S Pk[2 ðÞ       S Pk[j ðÞ       S Pk[11 ðÞ
. .
. . .
. . .
. . .
. . .
. . .
.
S Pm[1 ðÞ S Pm[2 ðÞ       S Pm[j ðÞ       S Pm[11 ðÞ
2
6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 5
ð4Þ
where
S(Pk[j)~
Xn
i~1 wk,ifi,j ð5Þ
The 11 elements of each row in Eq.4 represent the likelihoods that
protein Pk is secreted into the 11 body fluids, respectively. It can
be seen from Eq.5 that the likelihood S(Pk[j) can be formulated
as the sum of the interaction confidence scores of the protein Pk
with its interacting proteins that can be secreted into the j-th body
fluid Fj. Such scoring approach takes both the interaction
confidence score and the number of the interacting proteins into
consideration, just like the weighted vote. Obviously, the higher
the score, the more likely Pk is to be secreted into the j-th body
fluid Fj. In Eq.4, the 11 scores in the k-th row for the query
protein Pk are used to reflect the likelihoods that it is secreted into
the 11 body fluids, respectively. Accordingly, the most likely body
fluid Fm where Pk is secreted should be the one with the maximum
score, as can be formulated below
m~arg maxj S(Pk[j)jj~1,2,   ,11 fg ð 6Þ
where m is the j that maximizes the value of S(Pk[j).
Since many secreted proteins can be secreted into more than
one body fluid, our method is dedicated to provide flexible infor-
mation by predicting possible body fluids for secreted proteins,
Figure 1. The numbers of proteins that are secreted in different types of body fluids. See Table 1 for the definition of the numerical codes
used here for the body fluid types.
doi:10.1371/journal.pone.0022989.g001
ð4Þ
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the 11 elements of each row in Eq.4 according to descending
order. By doing so, we obtain a m|11 matrix as formulated by
D;M~
Q1 P1 ðÞQ2 P1 ð Þ     Qu P1 ð Þ     Q11 P1 ðÞ
Q1 P2 ðÞQ2 P2 ð Þ     Qu P2 ð Þ     Q11 P2 ðÞ
. .
. . .
. . .
. . .
. . .
. . .
.
Q1 Pk ðÞQ2 Pk ðÞ    Qu Pk ðÞ    Q11 Pk ðÞ
. .
. . .
. . .
. . .
. . .
. . .
.
Q1 Pm ðÞ Q2 Pm ð Þ     Qu Pm ð Þ     Q11 Pm ðÞ
2
6 6 6 6 6 6 6 6 6 6 6 6 6 4
3
7 7 7 7 7 7 7 7 7 7 7 7 7 5
k~1,2,   ,m
u~1,2,   ,11
 !
ð7Þ
where D; is a descending operator that arranges the 11 S(Pk[j)
of each row in Eq.4 in descending order: Q1(Pk)§Q2(Pk)
§   §Qu(Pk)§   §Q11(Pk). If two or more elements of the
row in Eq.4 are equal to one another, they will be sorted in
random order. Accordingly, the predicted results for the secreted
protein Pk can be obtained from the descending order. For
instance, if Q1(Pk)~S(Pk[3), Q2(Pk)~S(Pk[6), and Q3(Pk)
~S(Pk[11), then that the query protein P is secreted into the 3
rd
body fluid (Cerebrospinal fluid) will have the maximum likelihood
(cf. Table 1), that P is secreted into the 6
th body fluid (Plasma/
Serum) will have the second maximum likelihood, and that P is
secreted into the 11
th body fluid (Urine) will have the third
maximum likelihood. And so forth. The predicted results thus
obtained are called the 1
st order predicted body fluid, the 2
nd order
predicted body fluid, the 3
rd order predicted body fluid, and so
forth.
Validation and Demonstration
In statistical prediction, the following three cross-validation
methods are often used to examine a predictor for its effectiveness
in practical application: independent dataset test, subsampling test,
and jackknife test [36]. However, of the three test methods, the
jackknife test is deemed the most objective [37,38]. The reasons
are as follows. (1) For the independent dataset test, although all
the proteins used to test the predictor are outside the training
dataset used to train it so as to exclude the ‘‘memory’’ effect or
bias, the way of how to select the independent proteins to test
the predictor could be quite arbitrary unless the number of
independent proteins is sufficiently large. This kind of arbitrariness
might result in completely different conclusions. For instance, a
predictor achieving a higher success rate than the other predictor
for a given independent testing dataset might fail to keep so when
tested by another independent testing dataset [36]. (2) For the
subsampling test, the concrete procedure usually used in literatures
is the 5-fold, 7-fold or 10-fold cross-validation. The problem with
this kind of subsampling test is that the number of possible
selections in dividing a benchmark dataset is an astronomical
figure even for a very simple dataset, as demonstrated by Eqs.28–
30 in [23]. Therefore, in any actual subsampling cross-validation
tests, only an extremely small fraction of the possible selections are
taken into account. Since different selections will always lead to
different results even for a same benchmark dataset and a same
predictor, the subsampling test cannot avoid the arbitrariness
either. A test method unable to yield a unique outcome cannot be
deemed as a good one. (3) In the jackknife test, all the proteins in
the benchmark dataset will be singled out one-by-one and tested
by the predictor trained by the remaining protein samples. During
the process of jackknifing, both the training dataset and testing
dataset are actually open, and each protein sample will be in turn
moved between the two. The jackknife test can exclude the
‘‘memory’’ effect. Also, the arbitrariness problem as mentioned
above for the independent dataset test and subsampling test can be
avoided because the outcome obtained by the jackknife cross-
validation is always unique for a given benchmark dataset.
Accordingly, the jackknife test has been increasingly and widely
used by those investigators with strong math background to
examine the quality of various predictors (see, e.g., [39,40,41,
42,43,44,45,46,47,48]). In view of this, here the jackknife cross-
validation was also used to examine the prediction quality of the
network-based method. Meanwhile, just for a demonstration to
show biologists how to use the predictor for practical application,
we also performed the computation for some independent
datasets.
For the j-th order prediction, the accuracy Wj obtained by the
jackknife test can be formulated as
Wj~
Mj
N
(j~1,2,:::,11) ð8Þ
where Mj represents the number of the secreted proteins whose j-
th order predicted body fluid is one of the true body fluids where
the protein is secreted, and N represents the total number of
proteins in the PPI network. These 11-order jackknife cross-
validation accuracies were used as an evaluation for the network-
based method. According to Eq.8, high Wj with small j and low Wj
with large j will indicate a good prediction based on the current
prediction method.
In the PPI network, the average number of body fluids that each
secreted protein is secreted into can be calculated by
SWT~
X n
i~1
Ei
N
ð9Þ
where Ei represents the number of body fluids that the secreted
protein Pi is secreted into. Hence, a new evaluation for the
network-based method was proposed to calculate the likelihood
that the first k order predicted body fluids contain all the true body
fluids that the proteins can be secreted; it can be formulated as
Lk~
X k
u~1
Wu
X 11
j~1
Wj
ð10Þ
where k represents the smallest integer equal or greater than SWT
of Eq.9. Also, a large Lk indicates a good prediction of the
network-based method.
Results and Discussion
Performance of network-based method
In this study, the network-based method was applied to the
529 human secreted proteins to predict the body fluids where
they were secreted. All the 11 order jackknife cross-validation
Protein Body Fluids Prediction
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curve, we can see that except the 8
th-order prediction accuracy, all
the other higher-order prediction accuracies are higher than the
lower-order ones, indicting that the body fluids were well
prioritized for the proteins by the method. The 1
st-order (most
likely) prediction accuracy is 79.02%, indicating that the 1
st-order
predicted body fluid for the secreted proteins is believable. The
11
th-order (least likely) prediction accuracy is 6.99%, indicting that
the likelihood that the query protein is secreted into the 11
th-order
predicted body fluid is very low and such predicted body fluid can
be ignored.
The average number of body fluids that each secreted protein in
the PPI network can be secreted into is 3.23 according to Eq.9.
Hence, a random guess of body fluid for the secreted proteins will
have a 29.36% (3.23/11) success rate, lower than the first 5 order
prediction accuracies. The parameter k (cf. Eq.10) was set to be 4
([3.23]+1), i.e., we consider the first 4 order predicted body fluids
from the 11 order prediction. The likelihood that the first 4 order
predicted body fluids contain all the true body fluids that the
proteins can be secreted into is 0.6294 according to Eq.10,
indicating that the first 4 order predicted body fluids should be
paid more attention to than others in the 11 predicted body fluids.
The availability of using the PPI information to predict
the body fluids that secreted proteins can be secreted
into
Many important biological activities are mediated by proteins
interactions. The interacting proteins should co-occur spatially
and temporally to intact with each other [34]. Similarly, the
interacting secreted proteins often are secreted into the same body
fluids to perform their functions. For example, peptidoglycan
recognition protein 1 (O75594, UniProt Protein) can be secreted
into plasma/serum [49], saliva [50,51], and urine [52,53,54]. Its
interactions with the other proteins are shown in Table 2. Except
3 proteins (P07492, Q13410, and P05814), the other 20 neighbor
Figure 2. All the 11 order jackknife cross-validation accuracies
by the network-based method for the 529 human secreted
proteins.
doi:10.1371/journal.pone.0022989.g002
Table 2. Interactions of peptidoglycan recognition protein 1 (O75594, UniProt Protein) with its neighbor proteins in the PPI
network.
Protein A Body fluid type number
a Protein B Body fluid type number
a Interaction confidence
O75594 6, 7, 11 P61626 1, 2, 3, 4, 6, 7, 8, 10, 11 0.532
O75594 6, 7, 11 O15263 7 0.501
O75594 6, 7, 11 P05231 6 0.300
O75594 6, 7, 11 P13500 6 0.291
O75594 6, 7, 11 P60022 6, 11, 7 0.291
O75594 6, 7, 11 P01350 6 0.286
O75594 6, 7, 11 P78380 11 0.279
O75594 6, 7, 11 P07492 8 0.257
O75594 6, 7, 11 P02743 3, 6, 7, 8, 9, 10, 11 0.249
O75594 6, 7, 11 P05120 6, 7, 10 0.243
O75594 6, 7, 11 P35858 1, 3, 6, 9, 11 0.235
O75594 6, 7, 11 P49913 1, 6, 7, 8, 11 0.232
O75594 6, 7, 11 P01375 6 0.227
O75594 6, 7, 11 Q13410 4, 5 0.221
O75594 6, 7, 11 P48023 6 0.218
O75594 6, 7, 11 P19883 6 0.207
O75594 6, 7, 11 P05814 3, 4, 5 0.196
O75594 6, 7, 11 P11226 6 0.191
O75594 6, 7, 11 Q14116 6 0.162
O75594 6, 7, 11 P13236 6 0.156
O75594 6, 7, 11 P02788 1, 3, 5, 6, 7, 8, 10, 11 0.154
O75594 6, 7, 11 P13501 6 0.154
O75594 6, 7, 11 P13591 3, 6, 11 0.154
aSee Table 1 for the definition of the body fluid type number.
doi:10.1371/journal.pone.0022989.t002
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just like peptidoglycan recognition protein 1. According to the
prediction criteria, when peptidoglycan recognition protein 1 was
considered as a query protein, the first three order predicted body
fluids that peptidoglycan recognition protein 1 can be secreted into
are plasma/serum, saliva, and urine, which are consistent with the
real locations.
Further demonstration
Now, let us demonstrate the prediction method on an in-
dependent testing dataset that contains 57 blood-secreted proteins
(Table S1). The 11 order prediction accuracies for the 57 blood-
secreted proteins by the network-based method are listed in
Table 3. The 1
st prediction accuracy is 96.49%, i.e., 55 of 57
proteins were predicted to be secreted into plasma/serum in the 1
st
prediction. And the 2
nd prediction accuracy is 3.51%, and all the
other accuracies are 0. In other words, the first 2 predictions cover
the secreted locations of all the 57 blood-secreted proteins.
Apparently, the results indicate a good performance of the
network-based method for secreted proteins in blood. Except the
proteins in the training dataset and the 57 blood-secreted proteins,
few secreted proteins in other body fluids have been found in the
present researches. Therefore our method was evaluated on the
blood-secreted proteins.
Disease biomarker discovery
The 61 possible marker proteins listed in Table S2 were
also used to demonstrate our method. The 11 order prediction
accuracies for the 61 marker proteins are listed in Table 4. The 1
st
prediction accuracy is 95.08%, indicating 58 of 61 proteins were
predicted to be secreted into plasma/serum in the 1
st prediction.
The remaining 3 proteins were arranged into the plasma/serum in
the 2
nd and 3
rd prediction. The collected 61 biomarkers were well
arranged into the correct body fluid (plasma/serum).
Based on the quite promising results obtained through this
study, we can now propos a way to discover disease biomarker
in body fluids. After screening the proteins showing abnormal
expression levels in various diseases and identifying their sub-
cellular locations [11,12,13,14,15,18,19], they can be arranged
into body fluids using our method. Therefore, suitable biomarkers,
such as proteins in plasma/serum or urine can be discovered.
Application and improvement
As is discussed above, the predicted body fluids of the first 4
orders can be regarded as the candidate locations of the secreted
proteins. Biologists can focus on these body fluid candidates, which
can save a lot of time and labor so as to accelerate the research
progress. The predicted body fluids with the last 5 or 6 orders
might be excluded for consideration owing to their low accuracies.
Considering the effectiveness of the network-based method for
human secreted protein, it is possible to apply the current method
to predict the locations of secreted proteins in other species. The
PPI network can be collected from numerous sources including
STRING [27] (Version 8.0 covered 630 organisms), worm PPI
database [15], fly database [55], human PPI database [56,57,58],
BIND [59], BioGRID [60], CYGD [61], DIP [62], HPRD [63],
MINT [64], IntAct [65], and so forth. Based on the approach
proposed in this paper, we can predict the body fluids for proteins
of other organisms as well.
The performance of the network-based method can be further
improved via the following two avenues. The first one is to collect
the PPI data of high quality to exclude the false positive inter-
action, which was expected to improve the prediction accuracies.
The second way is to collect as much PPI data as possible for
constructing the PPI network, which was expected to make the
method cover as many secreted proteins as possible.
Conclusion
In this study, a multi-target model was developed for assigning
the human secreted proteins to the body fluid categories based on
the PPI network. Since it is the first computational method to
annotate the body fluids where human protein can be secreted
into, it is anticipated that the method will benefit the relevant
experimental researches and stimulate a series of follow-up
investigations into this emerging and challenging area.
Supporting Information
Table S1 The 57 blood-secreted proteins used to test the
network-based method.
(DOC)
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